Evidence map›Paper›PMID 17641157›Full record

ArticleAmerican journal of respiratory and critical care medicine2007

Early interstitial lung disease in familial pulmonary fibrosis.

Ivan O Rosas, Ping Ren, Nilo A Avila, Catherine K Chow, Teri J Franks, William D Travis, J Philip McCoy, Rose M May, Hai-Ping Wu, Dao M Nguyen and 3 more

Abstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 5 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 5 syntheses or guidelines pooled it, 185 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines.European respiratory review : an official journal of the European Respiratory Society · 2014
    Guideline
  4. Guideline
  5. Non-steroid agents for idiopathic pulmonary fibrosis.The Cochrane database of systematic reviews · 2010
    Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Genetic Familial Interstitial Lung Disease.Clinics in chest medicine · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Ivan O RosasPulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1590, USA.
Ping Ren
Nilo A Avila
Catherine K Chow
Teri J Franks
William D Travis
J Philip McCoy
Rose M May
Hai-Ping Wu
Dao M Nguyen
Mauricio Arcos-Burgos
Sandra D MacDonald
Bernadette R Gochuico
National Institutes of Health · USArmed Forces Institute of Pathology · US

Funding

Novel Therapeutic Strategies for Thoracic MalignanciesZ01BC010519 · NCI · BASIC SCIENCES · PI NGUYEN, DAO M · 2003 to 2007
$1.9M
Interstitial Lung DiseaseZ01HL002543 · NHLBI · HEART, LUNG, AND BLOOD INSTITUTE · PI GOCHUICO, BERNADETTE R · 1999 to 2006
–
Intramural NIH HHS
6 · The paper itself

Abstract

rationaleIdentification of early, asymptomatic interstitial lung disease (ILD) in populations at risk of developing idiopathic pulmonary fibrosis (IPF) may improve the understanding of the natural history of IPF.

objectivesTo determine clinical, radiographic, physiologic, and pathologic features of asymptomatic ILD in family members of patients with familial IPF.

methodsOne hundred sixty-four subjects from 18 kindreds affected with familial IPF were evaluated for ILD. Bronchoalveolar lavage fluid cells were analyzed using flow cytometry. Lung biopsies were performed in six subjects with asymptomatic ILD. MEASUREMENTS AND MAIN

resultsHigh-resolution computed tomography abnormalities suggesting ILD were identified in 31 (22%) of 143 asymptomatic subjects. Subjects with asymptomatic ILD were significantly younger than subjects with known familial IPF (P < 0.001) and significantly older than related subjects without lung disease (P < 0.001). A history of smoking was identified in 45% of subjects with asymptomatic ILD and in 67% of subjects with familial IPF; these percentages were significantly higher than that of related subjects without lung disease (23%) (P = 0.02 and P < 0.001, respectively). Percentages of activated CD4(+) lymphocytes were significantly higher in bronchoalveolar lavage fluid cells from subjects with asymptomatic ILD compared with related subjects without lung disease (P < 0.001). Lung biopsies performed in subjects with asymptomatic ILD revealed diverse histologic subtypes.

conclusionsAsymptomatic ILD in individuals at risk of developing familial IPF can be identified using high-resolution computed tomography scan of the chest, especially in those with a history of smoking. Lung biopsies from individuals in this cohort with early asymptomatic lung disease demonstrate various histologic subtypes of ILD.

Indexed as

AdultAgedBiopsyBronchoalveolar Lavage FluidFemaleHumansLungLung Diseases, InterstitialLymphocyte ActivationMaleMiddle AgedPulmonary FibrosisSmoking

Identifiers

PMID17641157
PMCPMC1994234
OpenAlexW2017139263

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.